Concomitant Therapy

Concomitant Therapy is a therapeutic regimen in the context of Helicobacter pylori eradication that involves the simultaneous administration of a proton pump inhibitor, clarithromycin, amoxicillin, and metronidazole for a fixed duration, typically 10 to 14 days, to maximize bacterial eradication through multi-antibiotic synergy without sequential prioritization.

2.8K

Publications

143.3K

Citations

16.1K

Authors

3.8K

Institutions

Publications per year

2017–2026

657

Authors

16.1K

  1. DY
    David Y. Graham

    Baylor College of Medicine, United States

    32 publications · 2.2K citations

    23

    h-index

  2. JP
    Javier P. Gisbert

    Hospital Universitario de La Princesa, Spain

    28 publications · 1.5K citations

    19

    h-index

  3. PH
    Ping‐I Hsu

    Kaohsiung Veterans General Hospital, Taiwan

    15 publications · 898 citations

    15

    h-index

  4. DW
    Deng‐Chyang Wu

    Kaohsiung Medical University, Taiwan

    14 publications · 656 citations

    14

    h-index

  5. TF
    Takahisa Furuta

    Hamamatsu University School of Medicine, Japan

    15 publications · 587 citations

    13

    h-index

1–5 of 16.1K

Venues

  1. Alimentary Pharmacology & Therapeutics

    139 publications · 6.9K citations

    52

    h-index

  2. PubMed

    Repository · 280 publications · 9.7K citations

    48

    h-index

  3. Helicobacter

    105 publications · 4.1K citations

    40

    h-index

  4. The American Journal of Gastroenterology

    AJG · 43 publications · 2.8K citations

    27

    h-index

  5. British Journal of Clinical Pharmacology

    BJCP · 29 publications · 1.6K citations

    24

    h-index

1–5